HARRELL INVESTMENT PARTNERS, LLC

Position in NVS — Novartis AG

CIK 1802882 AUSTIN, TX

Position in NVS

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$1,018,366

+$27,019 QoQ

Shares Held

6,498

+0.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

#611

of 1,603 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

HARRELL INVESTMENT PARTNERS, LLC holds $21,101,607 across 6 Drug Manufacturers - General names. NVS ranks #3 (4.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	40,541	$10,296,197
2	ABBV	AbbVie Inc.	31,506	$7,928,169
3	NVS	Novartis AG This page	6,498	$1,018,366
4	NVO	Novo Nordisk A S	16,042	$769,053
5	LLY	ELI LILLY & Co	584	$700,467
6	MRK	Merck & Co., Inc.	3,030	$389,355

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,018,366	6,498	+0.1%	Shares	Sole	2026-07-09
2026-03-31	$991,347	6,490	-2.3%	Shares	Sole	2026-04-22
2025-12-31	$915,456	6,640	+0.9%	Shares	Sole	2026-01-15
2025-09-30	$844,203	6,583	+4.8%	Shares	Sole	2025-10-23
2025-06-30	$759,821	6,279	—	Shares	Sole	2025-07-15
No filing history on record for this holder in this stock.